{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:28:22Z","timestamp":1777627702190,"version":"3.51.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["449436\/2014-4"],"award-info":[{"award-number":["449436\/2014-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310113\/2017-2"],"award-info":[{"award-number":["310113\/2017-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308449\/2016-9"],"award-info":[{"award-number":["308449\/2016-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11302-019-09681-2","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T17:38:27Z","timestamp":1576517907000},"page":"491-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The antidepressant-like effect of guanosine is dependent on GSK-3\u03b2 inhibition and activation of MAPK\/ERK and Nrf2\/heme oxygenase-1 signaling pathways"],"prefix":"10.1007","volume":"15","author":[{"given":"Priscila B.","family":"Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E. B.","family":"Bettio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian B.","family":"Neis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgana","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Werle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo B.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"issue":"12","key":"9681_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","volume":"59","author":"EJ Nestler","year":"2006","unstructured":"Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59(12):1151\u20131159. https:\/\/doi.org\/10.1016\/j.biopsych.2005.09.018","journal-title":"Biol Psychiatry"},{"issue":"3\u20134","key":"9681_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jpsychires.2006.05.008","volume":"41","author":"CB Nemeroff","year":"2007","unstructured":"Nemeroff CB (2007) The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res 41(3\u20134):189\u2013206. https:\/\/doi.org\/10.1016\/j.jpsychires.2006.05.008","journal-title":"J Psychiatr Res"},{"issue":"9995","key":"9681_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"Global Burden of Disease Study C","year":"2015","unstructured":"Global Burden of Disease Study C (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743\u2013800. https:\/\/doi.org\/10.1016\/S0140-6736(15)60692-4","journal-title":"Lancet"},{"issue":"2","key":"9681_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7(2):137\u2013151. https:\/\/doi.org\/10.1038\/nrn1846","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 3","key":"9681_CR5","first-page":"667","volume":"29","author":"M Agius","year":"2017","unstructured":"Agius M, Bonnici H (2017) Antidepressants in use in clinical practice. Psychiatr Danub 29(Suppl 3):667\u2013671","journal-title":"Psychiatr Danub"},{"issue":"12","key":"9681_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.biopsych.2012.11.011","volume":"73","author":"JM Dwyer","year":"2013","unstructured":"Dwyer JM, Duman RS (2013) Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants. Biol Psychiatry 73(12):1189\u20131198. https:\/\/doi.org\/10.1016\/j.biopsych.2012.11.011","journal-title":"Biol Psychiatry"},{"issue":"2","key":"9681_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.canlet.2004.09.042","volume":"224","author":"JS Lee","year":"2005","unstructured":"Lee JS, Surh YJ (2005) Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 224(2):171\u2013184. https:\/\/doi.org\/10.1016\/j.canlet.2004.09.042","journal-title":"Cancer Lett"},{"issue":"2","key":"9681_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.niox.2011.02.007","volume":"25","author":"A Uruno","year":"2011","unstructured":"Uruno A, Motohashi H (2011) The Keap1-Nrf2 system as an in vivo sensor for electrophiles. Nitric Oxide 25(2):153\u2013160. https:\/\/doi.org\/10.1016\/j.niox.2011.02.007","journal-title":"Nitric Oxide"},{"issue":"1","key":"9681_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.taap.2009.06.009","volume":"244","author":"SK Niture","year":"2010","unstructured":"Niture SK, Kaspar JW, Shen J, Jaiswal AK (2010) Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 244(1):37\u201342. https:\/\/doi.org\/10.1016\/j.taap.2009.06.009","journal-title":"Toxicol Appl Pharmacol"},{"issue":"18","key":"9681_CR10","doi-asserted-by":"publisher","first-page":"11908","DOI":"10.1073\/pnas.172398899","volume":"99","author":"AT Dinkova-Kostova","year":"2002","unstructured":"Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 99(18):11908\u201311913. https:\/\/doi.org\/10.1073\/pnas.172398899","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"9681_CR11","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.2174\/1381612824666180717160623","volume":"24","author":"VB Neis","year":"2018","unstructured":"Neis VB, Rosa PB, Moretti M, Rodrigues ALS (2018) Involvement of heme oxygenase-1 in neuropsychiatric and neurodegenerative diseases. Curr Pharm Des 24(20):2283\u20132302. https:\/\/doi.org\/10.2174\/1381612824666180717160623","journal-title":"Curr Pharm Des"},{"issue":"10","key":"9681_CR12","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.psyneuen.2013.03.020","volume":"38","author":"MD Martin-de-Saavedra","year":"2013","unstructured":"Martin-de-Saavedra MD, Budni J, Cunha MP, Gomez-Rangel V, Lorrio S, Del Barrio L, Lastres-Becker I, Parada E, Tordera RM, Rodrigues ALS, Cuadrado A, Lopez MG (2013) Nrf2 participates in depressive disorders through an anti-inflammatory mechanism. Psychoneuroendocrinology 38(10):2010\u20132022. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.03.020","journal-title":"Psychoneuroendocrinology"},{"issue":"5600","key":"9681_CR13","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"GL Johnson","year":"2002","unstructured":"Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298(5600):1911\u20131912. https:\/\/doi.org\/10.1126\/science.1072682","journal-title":"Science"},{"key":"9681_CR14","doi-asserted-by":"publisher","first-page":"971712","DOI":"10.1155\/2013\/971712","volume":"2013","author":"XB Meng","year":"2013","unstructured":"Meng XB, Sun GB, Wang M, Sun J, Qin M, Sun XB (2013) P90RSK and Nrf2 activation via MEK1\/2-ERK1\/2 pathways mediated by notoginsenoside R2 to prevent 6-hydroxydopamine-induced apoptotic death in SH-SY5Y cells. Evid Based Complement Alternat Med 2013:971712. https:\/\/doi.org\/10.1155\/2013\/971712","journal-title":"Evid Based Complement Alternat Med"},{"issue":"21","key":"9681_CR15","doi-asserted-by":"publisher","first-page":"12434","DOI":"10.1021\/es401791s","volume":"47","author":"W Zou","year":"2013","unstructured":"Zou W, Chen C, Zhong Y, An J, Zhang X, Yu Y, Yu Z, Fu J (2013) PI3K\/Akt pathway mediates Nrf2\/ARE activation in human L02 hepatocytes exposed to low-concentration HBCDs. Environ Sci Technol 47(21):12434\u201312440. https:\/\/doi.org\/10.1021\/es401791s","journal-title":"Environ Sci Technol"},{"issue":"11","key":"9681_CR16","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2174\/1389450110607011421","volume":"7","author":"RS Jope","year":"2006","unstructured":"Jope RS, Roh MS (2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7(11):1421\u20131434. https:\/\/doi.org\/10.2174\/1389450110607011421","journal-title":"Curr Drug Targets"},{"issue":"2","key":"9681_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/sj.mp.4000494","volume":"4","author":"RS Jope","year":"1999","unstructured":"Jope RS (1999) Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 4(2):117\u2013128","journal-title":"Mol Psychiatry"},{"issue":"3","key":"9681_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327","volume":"72","author":"G Chen","year":"1999","unstructured":"Chen G, Huang LD, Jiang YM, Manji HK (1999) The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72(3):1327\u20131330. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0721327","journal-title":"J Neurochem"},{"issue":"2","key":"9681_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1034\/j.1399-5618.2002.40201.x","volume":"4","author":"X Li","year":"2002","unstructured":"Li X, Bijur GN, Jope RS (2002) Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord 4(2):137\u2013144. https:\/\/doi.org\/10.1034\/j.1399-5618.2002.40201.x","journal-title":"Bipolar Disord"},{"issue":"2","key":"9681_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.encep.2016.02.003","volume":"42","author":"JF Costemale-Lacoste","year":"2016","unstructured":"Costemale-Lacoste JF, Guilloux JP, Gaillard R (2016) The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: a review of the literature. Encephale 42(2):156\u2013164. https:\/\/doi.org\/10.1016\/j.encep.2016.02.003","journal-title":"Encephale"},{"issue":"11","key":"9681_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/mp.2011.47","volume":"16","author":"E Beurel","year":"2011","unstructured":"Beurel E, Song L, Jope RS (2011) Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 16(11):1068\u20131070. https:\/\/doi.org\/10.1038\/mp.2011.47","journal-title":"Mol Psychiatry"},{"issue":"11","key":"9681_CR22","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/npp.2010.105","volume":"35","author":"X Li","year":"2010","unstructured":"Li X, Jope RS (2010) Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35(11):2143\u20132154. https:\/\/doi.org\/10.1038\/npp.2010.105","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"9681_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/mp.2011.161","volume":"17","author":"JC Garza","year":"2012","unstructured":"Garza JC, Guo M, Zhang W, Lu XY (2012) Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3beta\/beta-catenin signaling. Mol Psychiatry 17(8):790\u2013808. https:\/\/doi.org\/10.1038\/mp.2011.161","journal-title":"Mol Psychiatry"},{"issue":"10","key":"9681_CR24","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/s0006-3223(03)00700-5","volume":"54","author":"TM Madsen","year":"2003","unstructured":"Madsen TM, Newton SS, Eaton ME, Russell DS, Duman RS (2003) Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis. Biol Psychiatry 54(10):1006\u20131014. https:\/\/doi.org\/10.1016\/s0006-3223(03)00700-5","journal-title":"Biol Psychiatry"},{"issue":"4","key":"9681_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0736-5748(00)00084-8","volume":"19","author":"R Ciccarelli","year":"2001","unstructured":"Ciccarelli R, Ballerini P, Sabatino G, Rathbone MP, D'Onofrio M, Caciagli F, Di Iorio P (2001) Involvement of astrocytes in purine-mediated reparative processes in the brain. Int J Dev Neurosci 19(4):395\u2013414. https:\/\/doi.org\/10.1016\/S0736-5748(00)00084-8","journal-title":"Int J Dev Neurosci"},{"issue":"3","key":"9681_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11302-016-9509-4","volume":"12","author":"LE Bettio","year":"2016","unstructured":"Bettio LE, Gil-Mohapel J, Rodrigues ALS (2016) Guanosine and its role in neuropathologies. Purinergic Signal 12(3):411\u2013426. https:\/\/doi.org\/10.1007\/s11302-016-9509-4","journal-title":"Purinergic Signal"},{"issue":"2","key":"9681_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbr.2012.06.021","volume":"234","author":"LE Bettio","year":"2012","unstructured":"Bettio LE, Cunha MP, Budni J, Pazini FL, Oliveira A, Colla AR, Rodrigues ALS (2012) Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K\/mTOR pathways. Behav Brain Res 234(2):137\u2013148. https:\/\/doi.org\/10.1016\/j.bbr.2012.06.021","journal-title":"Behav Brain Res"},{"key":"9681_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pbb.2014.10.002","volume":"127","author":"LE Bettio","year":"2014","unstructured":"Bettio LE, Freitas AE, Neis VB, Santos DB, Ribeiro CM, Rosa PB, Farina M, Rodrigues ALS (2014) Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress. Pharmacol Biochem Behav 127:7\u201314. https:\/\/doi.org\/10.1016\/j.pbb.2014.10.002","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"9681_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","volume":"62","author":"MP Kaster","year":"2012","unstructured":"Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues ALS (2012) Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 62(1):419\u2013426. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.018","journal-title":"Neuropharmacology"},{"issue":"1","key":"9681_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pbb.2006.07.030","volume":"85","author":"SC Barauna","year":"2006","unstructured":"Barauna SC, Kaster MP, Heckert BT, do Nascimento KS, Rossi FM, Teixeira EH, Cavada BS, Rodrigues ALS, Leal RB (2006) Antidepressant-like effect of lectin from Canavalia brasiliensis (ConBr) administered centrally in mice. Pharmacol Biochem Behav 85(1):160\u2013169. https:\/\/doi.org\/10.1016\/j.pbb.2006.07.030","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"9681_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/bf00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85(3):367\u2013370. https:\/\/doi.org\/10.1007\/bf00428203","journal-title":"Psychopharmacology"},{"key":"9681_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4056383","volume":"2018","author":"Cristine de Paula Nascimento-Castro","year":"2018","unstructured":"Nascimento-Castro CP, Wink AC, da Fonseca VS, Bianco CD, Winkelmann-Duarte EC, Farina M, Rodrigues ALS, Gil-Mohapel J, de Bem AF, Brocardo PS (2018) Antidepressant effects of probucol on early-symptomatic YAC128 transgenic mice for Huntington\u2019s disease. Neural Plast 2018:4056383. https:\/\/doi.org\/10.1155\/2018\/4056383","journal-title":"Neural Plasticity"},{"key":"9681_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bbr.2013.12.038","volume":"261","author":"VB Neis","year":"2014","unstructured":"Neis VB, Manosso LM, Moretti M, Freitas AE, Daufenbach J, Rodrigues ALS (2014) Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration. Behav Brain Res 261:336\u2013344. https:\/\/doi.org\/10.1016\/j.bbr.2013.12.038","journal-title":"Behav Brain Res"},{"issue":"5","key":"9681_CR34","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1007\/s12035-015-9192-4","volume":"53","author":"MP Cunha","year":"2016","unstructured":"Cunha MP, Budni J, Ludka FK, Pazini FL, Rosa JM, Oliveira A, Lopes MW, Tasca CI, Leal RB, Rodrigues ALS (2016) Involvement of PI3K\/Akt signaling pathway and its downstream intracellular targets in the antidepressant-like effect of creatine. Mol Neurobiol 53(5):2954\u20132968. https:\/\/doi.org\/10.1007\/s12035-015-9192-4","journal-title":"Mol Neurobiol"},{"issue":"4","key":"9681_CR35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.pharep.2014.03.004","volume":"66","author":"MP Cunha","year":"2014","unstructured":"Cunha MP, Budni J, Pazini FL, Oliveira A, Rosa JM, Lopes MW, Leal RB, Rodrigues ALS (2014) Involvement of PKA, PKC, CAMK-II and MEK1\/2 in the acute antidepressant-like effect of creatine in mice. Pharmacol Rep 66(4):653\u2013659. https:\/\/doi.org\/10.1016\/j.pharep.2014.03.004","journal-title":"Pharmacol Rep"},{"issue":"3","key":"9681_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.pharep.2017.01.010","volume":"69","author":"LM Manosso","year":"2017","unstructured":"Manosso LM, Moretti M, Rosa JM, Cunha MP, Rodrigues ALS (2017) Evidence for the involvement of heme oxygenase-1 in the antidepressant-like effect of zinc. Pharmacol Rep 69(3):497\u2013503. https:\/\/doi.org\/10.1016\/j.pharep.2017.01.010","journal-title":"Pharmacol Rep"},{"issue":"6","key":"9681_CR37","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.pharep.2017.05.009","volume":"69","author":"AB Ramos-Hryb","year":"2017","unstructured":"Ramos-Hryb AB, Cunha MP, Pazini FL, Lieberknecht V, Prediger RDS, Kaster MP, Rodrigues ALS (2017) Ursolic acid affords antidepressant-like effects in mice through the activation of PKA, PKC, CAMK-II and MEK1\/2. Pharmacol Rep 69(6):1240\u20131246. https:\/\/doi.org\/10.1016\/j.pharep.2017.05.009","journal-title":"Pharmacol Rep"},{"issue":"1","key":"9681_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpsychires.2013.10.014","volume":"48","author":"M Moretti","year":"2014","unstructured":"Moretti M, Budni J, Freitas AE, Rosa PB, Rodrigues ALS (2014) Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway. J Psychiatr Res 48(1):16\u201324. https:\/\/doi.org\/10.1016\/j.jpsychires.2013.10.014","journal-title":"J Psychiatr Res"},{"issue":"2","key":"9681_CR39","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/0003-2697(77)90043-4","volume":"83","author":"GL Peterson","year":"1977","unstructured":"Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83(2):346\u2013356. https:\/\/doi.org\/10.1016\/0003-2697(77)90043-4","journal-title":"Anal Biochem"},{"issue":"3","key":"9681_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033057","volume":"7","author":"FM Cordova","year":"2012","unstructured":"Cordova FM, Aguiar AS Jr, Peres TV, Lopes MW, Goncalves FM, Remor AP, Lopes SC, Pilati C, Latini AS, Prediger RD, Erikson KM, Aschner M, Leal RB (2012) In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function. PLoS One 7(3):e33057. https:\/\/doi.org\/10.1371\/journal.pone.0033057","journal-title":"PLoS One"},{"key":"9681_CR41","doi-asserted-by":"publisher","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","volume":"2","author":"C Otte","year":"2016","unstructured":"Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF (2016) Major depressive disorder. Nat Rev Dis Primers 2:16065. https:\/\/doi.org\/10.1038\/nrdp.2016.65","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"9681_CR42","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1476-5381.2009.00597.x","volume":"159","author":"AP Schmidt","year":"2010","unstructured":"Schmidt AP, Bohmer AE, Schallenberger C, Antunes C, Tavares RG, Wofchuk ST, Elisabetsky E, Souza DO (2010) Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice. Br J Pharmacol 159(6):1247\u20131263. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00597.x","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"9681_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/jnr.20327","volume":"79","author":"ER Vinade","year":"2005","unstructured":"Vinade ER, Schmidt AP, Frizzo ME, Portela LV, Soares FA, Schwalm FD, Elisabetsky E, Izquierdo I, Souza DO (2005) Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats. J Neurosci Res 79(1\u20132):248\u2013253. https:\/\/doi.org\/10.1002\/jnr.20327","journal-title":"J Neurosci Res"},{"issue":"6","key":"9681_CR44","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.euroneuro.2016.03.009","volume":"26","author":"Vivian Binder Neis","year":"2016","unstructured":"Neis VB, Moretti M, Bettio LE, Ribeiro CM, Rosa PB, Gon\u00e7alves FM, Lopes MW, Leal RB, Rodrigues ALS (2016) Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling. Eur Neuropsychopharmacol 26(6):959\u2013971. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.03.009","journal-title":"European Neuropsychopharmacology"},{"key":"9681_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jpsychires.2016.07.004","volume":"82","author":"FK Ludka","year":"2016","unstructured":"Ludka FK, Constantino LC, Dal-Cim T, Binder LB, Zomkowski A, Rodrigues ALS, Tasca CI (2016) Involvement of PI3K\/Akt\/GSK-3beta and mTOR in the antidepressant-like effect of atorvastatin in mice. J Psychiatr Res 82:50\u201357. https:\/\/doi.org\/10.1016\/j.jpsychires.2016.07.004","journal-title":"J Psychiatr Res"},{"key":"9681_CR46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.pnpbp.2018.05.001","volume":"86","author":"JM Rosa","year":"2018","unstructured":"Rosa JM, Pazini FL, Cunha MP, Colla ARS, Manosso LM, Mancini G, Souza ACG, de Bem AF, Prediger RD, Rodrigues ALS (2018) Antidepressant effects of creatine on amyloid beta1-40-treated mice: the role of GSK-3beta\/Nrf2 pathway. Prog Neuro-Psychopharmacol Biol Psychiatry 86:270\u2013278. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.05.001","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"6","key":"9681_CR47","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.pnpbp.2008.05.020","volume":"32","author":"AO Rosa","year":"2008","unstructured":"Rosa AO, Kaster MP, Binfare RW, Morales S, Martin-Aparicio E, Navarro-Rico ML, Martinez A, Medina M, Garcia AG, Lopez MG, Rodrigues ALS (2008) Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 32(6):1549\u20131556. https:\/\/doi.org\/10.1016\/j.pnpbp.2008.05.020","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"3","key":"9681_CR48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.neuroscience.2007.12.026","volume":"152","author":"R. Silva","year":"2008","unstructured":"Silva R, Mesquita AR, Bessa J, Sousa JC, Sotiropoulos I, Le\u00e3o P, Almeida OF, Sousa N (2008) Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta. Neuroscience 152(3):656\u2013669. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.12.026","journal-title":"Neuroscience"},{"issue":"3","key":"9681_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4306\/pi.2010.7.3.202","volume":"7","author":"DH Oh","year":"2010","unstructured":"Oh DH, Park YC, Kim SH (2010) Increased glycogen synthase kinase-3beta mRNA level in the hippocampus of patients with major depression: a study using the Stanley neuropathology consortium integrative database. Psychiatry Investig 7(3):202\u2013207. https:\/\/doi.org\/10.4306\/pi.2010.7.3.202","journal-title":"Psychiatry Investig"},{"issue":"2","key":"9681_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4161\/org.4.2.5851","volume":"4","author":"Y Komiya","year":"2008","unstructured":"Komiya Y, Habas R (2008) Wnt signal transduction pathways. Organogenesis 4(2):68\u201375. https:\/\/doi.org\/10.4161\/org.4.2.5851","journal-title":"Organogenesis"},{"issue":"6103","key":"9681_CR51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2012","unstructured":"Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338(6103):68\u201372. https:\/\/doi.org\/10.1126\/science.1222939","journal-title":"Science"},{"issue":"2","key":"9681_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0896-6273(03)00195-8","volume":"38","author":"JT Coyle","year":"2003","unstructured":"Coyle JT, Duman RS (2003) Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38(2):157\u2013160. https:\/\/doi.org\/10.1016\/S0896-6273(03)00195-8","journal-title":"Neuron"},{"issue":"8","key":"9681_CR53","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.biopsych.2004.01.008","volume":"55","author":"O Kaidanovich-Beilin","year":"2004","unstructured":"Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004) Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55(8):781\u2013784. https:\/\/doi.org\/10.1016\/j.biopsych.2004.01.008","journal-title":"Biol Psychiatry"},{"issue":"17","key":"9681_CR54","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1073\/pnas.92.17.7686","volume":"92","author":"DT Dudley","year":"1995","unstructured":"Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92(17):7686\u20137689. https:\/\/doi.org\/10.1073\/pnas.92.17.7686","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"9681_CR55","doi-asserted-by":"publisher","first-page":"18623","DOI":"10.1074\/jbc.273.29.18623","volume":"273","author":"MF Favata","year":"1998","unstructured":"Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273(29):18623\u201318632. https:\/\/doi.org\/10.1074\/jbc.273.29.18623","journal-title":"J Biol Chem"},{"key":"9681_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pnpbp.2015.01.008","volume":"59","author":"Luana M. Manosso","year":"2015","unstructured":"Manosso LM, Moretti M, Ribeiro CM, Gon\u00e7alves FM, Leal RB, Rodrigues ALS (2015) Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation. Prog Neuro-Psychopharmacol Biol Psychiatry 59:59\u201367. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.01.008","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"8","key":"9681_CR57","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s12272-009-1807-8","volume":"32","author":"YJ Surh","year":"2009","unstructured":"Surh YJ, Kundu JK, Li MH, Na HK, Cha YN (2009) Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Arch Pharm Res 32(8):1163\u20131176. https:\/\/doi.org\/10.1007\/s12272-009-1807-8","journal-title":"Arch Pharm Res"},{"issue":"8","key":"9681_CR58","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/mnfr.201501017","volume":"60","author":"S Qin","year":"2016","unstructured":"Qin S, Hou DX (2016) Multiple regulations of Keap1\/Nrf2 system by dietary phytochemicals. Mol Nutr Food Res 60(8):1731\u20131755. https:\/\/doi.org\/10.1002\/mnfr.201501017","journal-title":"Mol Nutr Food Res"},{"issue":"1\u20133","key":"9681_CR59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejphar.2009.04.056","volume":"614","author":"B Li","year":"2009","unstructured":"Li B, Jeong GS, Kang DG, Lee HS, Kim YC (2009) Cytoprotective effects of lindenenyl acetate isolated from Lindera strychnifolia on mouse hippocampal HT22 cells. Eur J Pharmacol 614(1\u20133):58\u201365. https:\/\/doi.org\/10.1016\/j.ejphar.2009.04.056","journal-title":"Eur J Pharmacol"},{"key":"9681_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.toxlet.2017.04.011","volume":"277","author":"X Zhao","year":"2017","unstructured":"Zhao X, Wang R, Xiong J, Yan D, Li A, Wang S, Xu J, Zhou J (2017) JWA antagonizes paraquat-induced neurotoxicity via activation of Nrf2. Toxicol Lett 277:32\u201340. https:\/\/doi.org\/10.1016\/j.toxlet.2017.04.011","journal-title":"Toxicol Lett"},{"issue":"7","key":"9681_CR61","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1074\/jbc.M207293200","volume":"278","author":"T Nguyen","year":"2003","unstructured":"Nguyen T, Sherratt PJ, Huang HC, Yang CS, Pickett CB (2003) Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 278(7):4536\u20134541. https:\/\/doi.org\/10.1074\/jbc.M207293200","journal-title":"J Biol Chem"},{"issue":"4","key":"9681_CR62","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1074\/jbc.M209195200","volume":"278","author":"D Stewart","year":"2003","unstructured":"Stewart D, Killeen E, Naquin R, Alam S, Alam J (2003) Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J Biol Chem 278(4):2396\u20132402. https:\/\/doi.org\/10.1074\/jbc.M209195200","journal-title":"J Biol Chem"},{"issue":"4","key":"9681_CR63","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/TA.0000000000000588","volume":"78","author":"Y Tan","year":"2015","unstructured":"Tan Y, Wang Q, She Y, Bi X, Zhao B (2015) Ketamine reduces LPS-induced HMGB1 via activation of the Nrf2\/HO-1 pathway and NF-kappaB suppression. J Trauma Acute Care Surg 78(4):784\u2013792. https:\/\/doi.org\/10.1097\/TA.0000000000000588","journal-title":"J Trauma Acute Care Surg"},{"issue":"20","key":"9681_CR64","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1074\/jbc.R900010200","volume":"284","author":"T Nguyen","year":"2009","unstructured":"Nguyen T, Nioi P, Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284(20):13291\u201313295. https:\/\/doi.org\/10.1074\/jbc.R900010200","journal-title":"J Biol Chem"},{"issue":"3","key":"9681_CR65","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/MCB.25.3.1089-1099.2005","volume":"25","author":"RN Karapetian","year":"2005","unstructured":"Karapetian RN, Evstafieva AG, Abaeva IS, Chichkova NV, Filonov GS, Rubtsov YP, Sukhacheva EA, Melnikov SV, Schneider U, Wanker EE, Vartapetian AB (2005) Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol Cell Biol 25(3):1089\u20131099. https:\/\/doi.org\/10.1128\/MCB.25.3.1089-1099.2005","journal-title":"Mol Cell Biol"},{"issue":"11","key":"9681_CR66","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1128\/MCB.25.11.4501-4513.2005","volume":"25","author":"M Velichkova","year":"2005","unstructured":"Velichkova M, Hasson T (2005) Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol Cell Biol 25(11):4501\u20134513. https:\/\/doi.org\/10.1128\/MCB.25.11.4501-4513.2005","journal-title":"Mol Cell Biol"},{"issue":"3","key":"9681_CR67","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.bbrc.2006.03.036","volume":"343","author":"M Hsu","year":"2006","unstructured":"Hsu M, Muchova L, Morioka I, Wong RJ, Schroder H, Stevenson DK (2006) Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun 343(3):738\u2013744. https:\/\/doi.org\/10.1016\/j.bbrc.2006.03.036","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"9681_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jnc.12694","volume":"130","author":"Andr\u00e9 Quincozes-Santos","year":"2014","unstructured":"Quincozes-Santos A, Bobermin LD, Souza DG, Bellaver B, Gon\u00e7alves CA, Souza DO (2014) Guanosine protects C6 astroglial cells against azide-induced oxidative damage: a putative role of heme oxygenase 1. J Neurochem 130(1):61\u201374. https:\/\/doi.org\/10.1111\/jnc.12694","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"9681_CR69","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11302-015-9475-2","volume":"11","author":"Bruna Bellaver","year":"2015","unstructured":"Bellaver B, Souza DG, Bobermin LD, Gon\u00e7alves CA, Souza DO, Quincozes-Santos A (2015) Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway. Purinergic Signal 11(4):571\u2013580. https:\/\/doi.org\/10.1007\/s11302-015-9475-2","journal-title":"Purinergic Signalling"},{"key":"9681_CR70","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.freeradbiomed.2014.10.753","volume":"75 Suppl 1","author":"A De Bem","year":"2014","unstructured":"De Bem A, Engel D, de Oliveira J, Moreira EL, Neis VB, Santos DB, Lopes JB, Rodrigues ALS, Brocardo P (2014) Hypercholesterolemia as a risk factor for depressive disorder? Free Radic Biol Med 75 Suppl 1:S28. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.10.753","journal-title":"Free Radic Biol Med"},{"key":"9681_CR71","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.freeradbiomed.2013.05.019","volume":"63","author":"J Rybka","year":"2013","unstructured":"Rybka J, Kedziora-Kornatowska K, Banas-Lezanska P, Majsterek I, Carvalho LA, Cattaneo A, Anacker C, Kedziora J (2013) Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression. Free Radic Biol Med 63:187\u2013194. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.05.019","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"9681_CR72","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/13510002.2015.1101889","volume":"21","author":"J Robaczewska","year":"2016","unstructured":"Robaczewska J, Kedziora-Kornatowska K, Kucharski R, Nowak M, Muszalik M, Kornatowski M, Kedziora J (2016) Decreased expression of heme oxygenase is associated with depressive symptoms and may contribute to depressive and hypertensive comorbidity. Redox Rep 21(5):209\u2013218. https:\/\/doi.org\/10.1080\/13510002.2015.1101889","journal-title":"Redox Rep"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-019-09681-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11302-019-09681-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-019-09681-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:57:13Z","timestamp":1606179433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11302-019-09681-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9681"],"URL":"https:\/\/doi.org\/10.1007\/s11302-019-09681-2","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"8 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were performed in accordance with the Guidelines of Ethic Committee on Animal Use of the Federal University of Santa Catarina (CEUA\/UFSC) the guidelines laid down by the NIH (NIH Guide for the Care and Use of Laboratory Animals) in the USA. The CEUA\/UFSC has approved all experimental protocols (approval numbers 00795 and 7485180518).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}